Connect with us

Tech

Net-Zero Emissions Quest Needs ‘Radical Collaboration’

Published

on

Companies are making net-zero emissions targets right and left. Some say they are already carbon neutral or net-zero, but until Thursday, there was no global standard for setting credible net-zero targets backed by climate science.

The Science Based Targets initiative’s (SBTi) net-zero emissions standard has rigorous requirements in line with the Paris Agreement’s pathway for limiting average global temperature rise to below 1.5 degrees Celsius.

Many experts deem transportation-related emissions “hard to abate” because of the reliance on fossil fuels, higher upfront costs for some sustainable solutions, long asset replacement cycles, and technological constraints.

During the net-zero standard launch Thursday, several industry experts echoed the need for “radical collaboration” among competitors, governments, and supply chain partners.

SBTi’s standard will not allow for heavy reliance on offsetting emissions to reach net-zero. Most companies will have to cut direct emissions (scope 1), indirect emissions from electricity and heat (scope 2), and emissions along the supply chain and from end-users (scope 3) by 90% to 95% by or before 2050.

Read: Why is reducing emissions in freight so hard?

The Scope of the Challenge

Supply chains are a major source of scope 3 emissions for retailers and other companies, but getting suppliers, logistics providers and carriers on the same page is no easy feat. Companies have much more control and influence over their scope 1 and scope 2 emissions.

Under this standard, companies will be required to include 95% of scope 1 and 2 emissions and 90% of scope 3 emissions, a significant jump from the 67% the initiative …
Full story available on Benzinga.comRead More

Source Here: benzinga.com

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Tech

Mereo BioPharma’s Etigilimab/Opdivo Combo Achieves One Complete Response in Cervical Cancer

Published

on

Mereo BioPharma Group plc (NASDAQ: MREO) reported interim data from ACTIVATE Phase 1b/2 study of its anti-TIGIT antibody, etigilimab, in combination with Bristol Myers Squibb Co (NYSE: BMY) Opdivo (nivolumab) in select recurrent advanced/metastatic solid tumors.
As of the cut-off date, one complete response in cervical cancer, one partial response in ovarian cancer, and four …
Full story available on Benzinga.comRead More

Original Article: benzinga.com

Continue Reading

Tech

Canada Plastics Pact Welcomes 15 New Partners

Published

on

OTTAWA, Nov. 30, 2021 (GLOBE NEWSWIRE) — Canada Plastics Pact is excited to be welcoming 15 new Partners following last month’s release of it’s shared action plan to build a circular economy for plastics packaging in Canada. The new Partners announced today include leading consumer goods organizations, provincial and municipal governments, resin producers, recyclers, a bio-based plastics startup, one of Canada’s largest waste management companies, a new non-profit Producer Responsibility Organization and leading non-profit organizations from across the country.
Since the CPP launched in January 2021, the CPP has doubled in size to include 81 leading industry, NGO, and public sector organizations who together account for over a third of the plastics packaging in the market nationally. These Partners are working collaboratively towards ambitious 2025 targets to create a circular economy for plastics packaging in Canada where it stays in the economy and out of the environment. This has included the release of Roadmap to 2025: A shared action plan to build a circular economy for plastics …
Full story available on Benzinga.comRead More

Article: benzinga.com

Continue Reading

Tech

HealthRecon Connect Successfully Completes SOC 1(R) Type 1 Examination

Published

on

DALLAS, Nov. 30, 2021 (GLOBE NEWSWIRE) — HealthRecon Connect, leading revenue cycle management solutions provider to Healthcare Providers based in the US, reaffirmed its commitment to internal security controls by successfully completing the System and Organizational Controls SOC 1(R) Type 1 examination. The report independently audited by Stakes CPA, LLC, validates that HealthRecon’s infrastructure, controls, policies, and procedures meet and/or exceeded the SOC 1(R) Type 1 criteria as of July 1, …
Full story available on Benzinga.comRead More

Source Here: benzinga.com

Continue Reading

Trending

BaypointNews.com